Page 164 - MI-2-3

Microbes & Immunity Hyphae and healthspan

tachycardia syndrome. Circ Cardiovasc Qual Outcomes. doi: 10.1016/j.ajhg.2016.08.019
2016;9.
82. Kak MM, Bharali J, Rastogi P, Chaubey KK. Role of mast
doi: 10.1161/circoutcomes.9.suppl_2.116 cells in periodontal health and disease: A comparative study.
Int J Appl Dent Sci. 2021;7(4):113-116.
71. Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr
virus reactivation is elevated in COVID-19 patients. Virus doi: 10.22271/ORAL.2021.V7.I4B.1361
Res. 2023;334:199157.
83. Jones MK, Nair A, Gupta M. Mast cells in neurodegenerative
doi: 10.1016/j.virusres.2023.199157 disease. Front Cell Neurosci. 2019;13:171.
72. Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of doi: 10.3389/fncel.2019.00171
long COVID Prevalence and its relationship to Epstein-Barr 84. Guo X, Sun M, Yang P, Meng X, Liu R. Role of mast cells
virus reactivation. Pathogens. 2021;10(6):763.
activation in the tumor immune microenvironment
doi: 10.3390/pathogens10060763 and immunotherapy of cancers. Eur J Pharmacol.
2023;960:176103.
73. Harley JB, Chen X, Pujato M, et al. Transcription factors
operate across disease loci, with EBNA2 implicated in doi: 10.1016/j.ejphar.2023.176103
autoimmunity. Nat Genet. 2018;50(5):699-707.
85. Kovanen PT, Bot I. Mast cells in atherosclerotic
doi: 10.1038/s41588-018-0102-3 cardiovascular disease - Activators and actions. Eur J
Pharmacol. 2017;816:37-46.
74. James JA, Harley JB, Scofield RH. Epstein-Barr virus and
systemic lupus erythematosus. Curr Opin Rheumatol. doi: 10.1016/j.ejphar.2017.10.013
2006;18(5):462-467.
86. Kaczmarczyk-Sekuła K, Dyduch G, Kostański M, et al. Mast
doi: 10.1097/01.bor.0000240355.37927.94 cells in systemic and cutaneous lupus erythematosus. Pol J
Pathol. 2015;66(4):397-402.
75. Trimarchi M, Lauritano D, Ronconi G, et al. Mast cell
cytokines in acute and chronic gingival tissue inflammation: doi: 10.5114/pjp.2015.57253
Role of IL-33 and IL-37. Int J Mol Sci. 2022;23(21):13242.
87. Suurmond J, Dorjée AL, Boon MR, et al. Mast cells are the
doi: 10.3390/ijms232113242 main interleukin 17-positive cells in anticitrullinated protein
antibody-positive and -negative rheumatoid arthritis and
76. Lagdive SS, Lagdive SB, Mani A, et al. Correlation of mast
cells in periodontal diseases. J Indian Soc Periodontol. osteoarthritis synovium. Arthritis Res Ther. 2015;17:354.
2013;17(1):63-67. doi: 10.1186/s13075-015-0847-3
doi: 10.4103/0972-124X.107500 88. Nakae S, Suto H, Berry GJ, Galli SJ. Mast cell-derived TNF
can promote Th17 cell-dependent neutrophil recruitment in
77. Yu M, Song XT, Liu B, Luan TT, Liao SL, Zhao ZT. The
emerging role of mast cells in response to fungal infection. ovalbumin-challenged OTII mice. Blood. 2007;109:3640-3648.
Front Immunol. 2021;12:688659. doi: 10.1182/blood-2006-09-046128

doi: 10.3389/fimmu.2021.688659 89. Kenna T, Brown MA. The role of IL-17-secreting mast
cells in inflammatory joint disease. Nat Rev Rheumatol.
78. Louisa M, Amalina A, Putranto RA, Komala ON,
Anggraini W. Periodontal disease severity in patients with 2012;9:375-379.
long COVID and non-COVID-19. Dent J. 2024;57(1):50-55. doi: 10.1038/nrrheum.2012.205
doi: 10.20473/j.djmkg.v57.i1.p50-55 90. De Zuani M, Dal Secco C, Frossi B. Mast cells at the crossroads
of microbiota and IBD. Eur J Immunol. 2018;48(12):1929-1937.
79. Schenkein HA, Berry CR, Burmeister JA, et al. Anti-
cardiolipin antibodies in sera from patients with doi: 10.1002/eji.201847504
periodontitis. J Dent Res. 2003;82(11):919-922.
91. Kempuraj D, Tagen M, Iliopoulou BP, et al. Luteolin inhibits
doi: 10.1177/154405910308201114 myelin basic protein-induced human mast cell activation
and mast cell-dependent stimulation of Jurkat T cells. Br J
80. Brooks JK, Francis LA. Postural orthostatic tachycardia
syndrome: Dental treatment considerations. J Am Dent Pharmacol. 2008;155:1076-1084.
Assoc. 2006;137(4):488-493. doi: 10.1038/bjp.2008.356
doi: 10.14219/jada.archive.2006.0221 92. Schofield JR. Persistent antiphospholipid antibodies, mast
cell activation syndrome, postural orthostatic tachycardia
81. Kapferer-Seebacher I, Pepin M, Werner R, et al. Periodontal
ehlers-danlos syndrome is caused by mutations in C1R syndrome and post-COVID syndrome: 1 year on. Eur J Case
and C1S, which encode subcomponents C r and C s of Rep Intern Med. 2021;8(3):002378.
1
1
complement. Am J Hum Genet. 2016;99(5):1005-1014. doi: 10.12890/2021_002378
Volume 2 Issue 3 (2025) 156 doi: 10.36922/mi.4736